Back to SNDX
GOLDMAN SACHS GROUP INC → SNDX
GOLDMAN SACHS GROUP INC SNDX Position History
Syndax Pharmaceuticals, Inc. • Healthcare
Quarters held
18
Latest value
$229K
Q2 2026
Peak value
$118.9M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $42.5M |
| Q1 2025 | $5.2M |
| Q1 2025 | $458K |
| Q2 2025 | $48.7M |
| Q2 2025 | $5.1M |
| Q2 2025 | $552K |
| Q3 2025 | $74.5M |
| Q3 2025 | $9M |
| Q3 2025 | $870K |
| Q4 2025 | $5.4M |
| Q4 2025 | $114.2M |
| Q4 2025 | $114.2M |
| Q4 2025 | $5.4M |
| Q1 2026 | $111.4M |
| Q1 2026 | $5.3M |
| Q2 2026 | $118.9M |
| Q2 2026 | $9M |
| Q2 2026 | $229K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $229K | 10.5K | — | — |
| Q2 2026 | $9M | 410.9K | — | — |
| Q2 2026 | $118.9M | 5.44M | — | — |
| Q1 2026 | $5.3M | 226.7K | — | — |
| Q1 2026 | $111.4M | 4.77M | — | — |
| Q4 2025 | $5.4M | 259.4K | — | — |
| Q4 2025 | $114.2M | 5.44M | — | — |
| Q4 2025 | $114.2M | 5.44M | — | — |
| Q4 2025 | $5.4M | 259.4K | — | — |
| Q3 2025 | $870K | 56.5K | — | — |
| Q3 2025 | $9M | 585.8K | — | — |
| Q3 2025 | $74.5M | 4.84M | — | — |
| Q2 2025 | $552K | 58.9K | — | — |
| Q2 2025 | $5.1M | 541.9K | — | — |
| Q2 2025 | $48.7M | 5.20M | — | — |
| Q1 2025 | $458K | 37.3K | — | — |
| Q1 2025 | $5.2M | 423.2K | — | — |
| Q1 2025 | $42.5M | 3.46M | — | — |
Other funds holding SNDX
$123.7M
$123.7M
$116.1M
$114.7M
$108.4M
$103.5M
$96.6M